## 



## 

|||||||||Page|
|---|---|---|---|---|---|---|---|---|
|Reference and Administrative<br>Details|||of the Charity,||its|Trustees and Advisors|||
|Chair's Statement|||||||||
|Report of the|Trustees|(incorporating|the strategic report)|||||3-13|
|Independent|Auditor's|Report||||||14 - 17|
|Consolidated|Statement<br>of Financial Activities|||lincluding||income and expenditure|account)|18|
|Consolidated|Balance|Sheet||||||19|
|Charity Balance Sheet||||||||20|
|Consolidated|Statement<br>of Cash Flows|||||||21|
|Notes to the|Financial|Statements||||||22 - 36|





|Name of Company:|Name of Company:|Name of Company:||Wakefield<br>Hospice|Wakefield<br>Hospice||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Registered||Address:||Aberford<br>Road|||||||||
|||||Wakefield|||||||||
|||||WF1 4TS|||||||||
|Status:||||Company<br>Limited||by Guarantee|||and a Registered||Charity||
|Company|Registration|||No:<br>02038416|||||||||
|Charity Registration|||No:<br>518392||||||||||
|The Trustees constitute||||Directors of the Charity||for|the purpose ofthe Companies|||||Act 2006 and the Trustees are the|
|officials of||the Charity||for the purpose of the|Charities Act|||1993. The following|||members were in office during the year||
|ended 31|March 2023:||||||||||||
|||||A P Howatson<br>(Chair)|||||||||
|||||H J Hirst (Vice Chair)|||||||||
|||||G W Cattell (Vice Chair)||(resigned||30|September|2022)|||
|||||DJ Martindale<br>(resigned||12|December||2022)||||
|||||M D Ashton|||||||||
|||||N gains-Williams|||||||||
|||||5 C Black (resigned 9August|||2023)||||||
|||||M L Denby (resigned|16|June|2022)||||||
|||||C J Phillips<br>(resigned|25 November|||2022)|||||
|||||RJOtter|||||||||
|||||A T Hamilton|||||||||
|||||8 C T Browne|||||||||
|||||L EClayton|||||||||
|||||J G Milne|||||||||
|||||L D Bateman<br>(appointed||12 December|||2022)||||
|||||C R Beck (appointed|12|December 2022)|||||||
|||||A Gait (appointed<br>12|December 2022)||||||||
|||||C Kendall<br>(appointed|12 December|||2022)|||||
|||||8 Ralph (appointed<br>12 December 2022)|||||||||
|Company|Secretary:|||A C Beedle|||||||||
|Senior Executives:||||T R Turner<br>- Chief Executive|||||||||
|||||Dr E Lowe<br>- Medical Director|||||||||
|||||H M Knowles<br>- Director of Fundraising|||||and Retail|Operations|||
|||||J Millard<br>- Director of Clinical Services|||||||||
|||||A C Beedle - Director|of Finance Estates and Resources||||||||
|Independent||Auditor:||Armstrong<br>Watson Audit||Limited|||||||
|||||Third Floor, 10South|Parade||||||||
|||||Leeds|||||||||
|||||LS1 5QS|||||||||
|Bankers:||||Royal Bank of Scotland pic|||||||||
|||||PO Box4862|||||||||
|||||5 Church Street|||||||||
|||||Sheffield|||||||||
|||||52 9EQ|||||||||
|Investment||Managers:||Brewin<br>Dolphin|||||||||
|||||Fourth Floor, 10Wellington|||Place||||||
|||||Leeds|||||||||
|||||LS1 4AN|||||||||





## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

|able<br>activities|||||||||
|---|---|---|---|---|---|---|---|---|
||||||||Year Ended 31.3.23|Year Ended 31.3.22|
|Core ICB/CCG<br>rants|||||||E1 191 662|E1 133658|
|%oftotal income|||||||26.2%|26.6%|
|Additional<br>ICB/CCG|fundin||||||E341 800||
|%oftotal income|||||||7.5%||
|In- atients admitted||durin|the|ear|||199|165|
|DTU service users|includin||Dementia||Da|Care|188|75|
|Number ofVolunteers||clinical||services|||34|26|
|Number ofvolunteers||Hos|ice|back office|||49|54|



## 

## 

||||Year Ended 31.3.23|Year Ended 31.3.22|
|---|---|---|---|---|
|Donations<br>and<br>ifts|||E404 603|E422 539|
|%oftotal income|||8.9%||
|Le acies|||E585 046|E566 122|
|%oftotal income|||12.8%|13.3%|
|Lotte|||E72 081|E65 295|
|Fundraisin<br>and other activities|||E610 104|E506 013|
|%oftotal income|||13.4%|11.9%|
|Number ofvolunteers|includin|event volunteers|109|125|
||||Year Ended 31.3.23|Year Ended 31.3.22|
|Sho<br>sales|||E714 145|E583 597|
|Online sales|||E214 735|E180921|
|Total retail income|||E928 880|E839405|
|%oftotal income|||20.4%|19.7%|
|Number of retail outlets|||||
|Number ofvolunteers|||140|130|



## 

|||||Year Ended 31.3.23|Year Ended 31.3.22|
|---|---|---|---|---|---|
|Turnover||||E31 784|E22 552|
|0 eratin|Profit|||E11 721|Eg 142|
|Gift Aid|distribution|to Wakefield|Hos ice|E11 721|E8 142|



## 



## 

## 




## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 




## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

|||||2023|2023|2023|2022|
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total|Total|
||||Notes|Funds|Funds|Funds|Funds|
|Income:||||E|E|E|E|
|Income from donations|and|legacies||1,151,980|23,479|1,175,459|1,292,472|
|Income from charitable|activities||5|1,659,623||1,659,623|1,441,191|
|Income from other trading||activities|6|1,665,017||1,665,017|1,457,709|
|Investment<br>income||||49,597||49,597|36,568|
|Other income|||||||31,702|
|Total Income||||4,526,217|23,479|4,549,696|4,259,642|
|Expenditure:||||||||
|Expenditure<br>on raising funds|||9|1,862,458||1,862,458|1,453,293|
|Expenditure<br>on charitable||activities|10|3,175,072|28,702|3,203,774|2,941,913|
|Total expenditure||||5,037,530|28,702|5,066,232|4,395,206|
|Net gains on investments|||16, 17|56,652||56,652|29,218|
|Net (expenditure) Iincome||||(454,661)|(5,223)|(459,884)|(106,346)|
|Transfers between<br>funds|||23|35,000|(35,000)|||
|Net movement<br>in funds||||(419,661)|(40,223)|(459,884)|(106,346)|
|Reconciliation<br>offunds:||||||||
|Total funds brought<br>forward||||6,271,733|114,689|6,386,422|6,492,768|
|Total funds carried forward|||23|5,852,072|74,466|5,926,538|6,386,422|





## 




## 





## 

|||Notes|2023|2023|2022|2022|
|---|---|---|---|---|---|---|
||||E|E|E|E|
|Cash flows from operating<br>activities:|||||||
|Net cash provided<br>by operating activities||||(383,284)||348,781|
|Cash flows from investing<br>activities:|||||||
|Dividends,<br>interest and rents from investments|||49,597||36,568||
|Purchase of property,<br>plant and equipment|||(219,323)||(53,853)||
|Proceeds from sale of properties|||167,997||80,114||
|Proceeds from sale of investments|||51,780||76,781||
|Purchase of investments|||(47,453)||(75,136)||
|Net cash provided<br>by investing activities||||2,598||64,474|
|Change<br>in cash and cash equivalents|in the|year||(380,686)||413,255|
|Cash and cash equivalents<br>at the beginning||ofthe year||2,077,226||1,663,971|
|Cash and cash equivalents<br>at the end|ofthe|year||1,696,540||2,077,226|
|Notes to the statement<br>ofcash flows|||||||
|a<br>Reconciliation<br>ofnet expenditure|to net|cash flow from operating|activities||||
||||||2023|2022|
||||||E|E|
|Net (expenditure)<br>/ income for the|year||||(459,884)|(106,346)|
|Depreciation<br>charges|||||147,060|143,154|
|Net gain on investments|||||(56,652)|(29,218)|
|Dividends,<br>interest<br>and rents from|investments||||(49,597)|(36,568)|
|Decrease<br>/ (increase)<br>in stocks|||||(6,704)|116|
|Decrease / (increase)<br>in debtors|||||(170,408)|1,498,803|
|(Decrease)<br>/ increase<br>in creditors|||||212,901|(1,035,265)|
|(Decrease)<br>/ increase<br>in provision||||||(85,895)|
|Net cash provided<br>by operating<br>activities|||||(383,284)|348,781|
|b<br>Analysis ofcash and cash equivalents|||||||
||||||2023|2022|
||||||E|E|
|Cash at bank and in hand|||||1,689,957|2,069,767|
|Cash held as part of the investment|portfolio||||6,583|7,459|
|Total cash and cash equivalents|||||1,696,540|2,077,226|





## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|Donations|and legacies|||||
|---|---|---|---|---|---|
|||2023|2023|2023|2022|
|||Unrestricted|Restricted|Total|Total|
|||Funds|Funds|Funds|Funds|
|||E|E|E|E|
|Donations|and gifts|404,603||404,603|422,539|
|Gift Aid||68,102||68,102|69,847|
|Legacies||585,046||585,046|566,122|
|Other Grants||94,229|23,479|117,708|233,964|
|||1,151,980|23,479|i,175,459|1,292,472|



## 

|Analysis ofincome from|charitable<br>activities|||||
|---|---|---|---|---|---|
|||2023|2023|2023|2022|
|||Unrestricted|Restricted|Total|Total|
|||Funds|Funds|Funds|Funds|
|||E|E|E|E|
|CCG grant for specialist|care|1,430,122||1,430,122|1,033,658|
|24/7 Admissions||103,340||103,340|100,000|
|Education||74,208||74,208|135,489|
|Other grants and claims|||||139,064|
|Sundries 8 expenditure|recharges|51,953||51,953|32,980|
|||1,659,623||1,659,623|1,441,191|



## 

|Analysis of|income fr|om other trading|activities|||||
|---|---|---|---|---|---|---|---|
|||||2023|2023|2023|2022|
|||||Unrestricted|Restricted|Total|Total|
|||||Funds|Funds|Funds|Funds|
|||||E|E|E|E|
|Fundraising|and other|activities||610,104||610,104|506,013|
|Retail income||||928,880||928,880|839,405|
|Lottery||||72,081||72,081|65,295|
|General income||||22,168||22,168|24,444|
|Trade from|Wakefie(d|Hospice Trading|Limited|31,784||31,784|22,552|
|||||1,665,017||1,665,017|1,457,709|





## 

## 

|Investm|ent<br>income||||||
|---|---|---|---|---|---|---|
||||2023|2023|2023|2022|
||||Unrestricted|Restricted|Total|Total|
||||Funds|Funds|Funds|Funds|
||||E|E|E|E|
|Income|from investment|properties|23,643||23,643|25,803|
|Income|from listed investments||12,199||12,199|10,403|
|Interest|receivable||13,755||13,755|362|
||||49,597||49,597|36,568|



## 

|2023|2023|2023|2022|
|---|---|---|---|
|Unrestricted|Restricted|Total|Total|
|Funds|Funds|Funds|Funds|
|E|E|E|E|
||||31,702|



## 

|Analysis o|fexp|end|iture<br>on|raising funds||||||
|---|---|---|---|---|---|---|---|---|---|
|||||||Activities|Support|||
|||||||undertaken|Costs|2023|2022|
|||||||directly|(see note 11)|Total|Total|
|||||||E|E|E|E|
|Fundraising||||||||||
|Wages|and|salaries||||312,064|135,904|447,968|332,141|
|Depreciation|||||||4,894|4,894|4,966|
|Other costs||||||205,567|34,236|239,803|173,654|
|||||||517,631|175,034|692,665|510,761|
|Retail||||||||||
|Wages|and|salaries||||586,455|144,651|731,106|591,932|
|Expenditure||of|Wakefield|Hospice Trading|Limited|20,063||20,063|14,410|
|Depreciation|||||||20,147|20,147|14,384|
|Other costs||||||306,997|42,710|349,707|272,087|
|||||||913,515|207,508|1,121,023|892,813|
|Other expenditure|||on raising|funds||||||
|Investment||management||fees||10,071||10,071|11,536|
|General|income||costs|||13,705||13,705|4,836|
|||||||23,776||23,776|16,372|
|Governance|(see note 11)||||||24,994|24,994|33,347|
|||||||1,454,922|407,536|1,862,458|1,453,293|





## 

## 

|Analysis ofexpen|diture<br>on charitable<br>activities|||||
|---|---|---|---|---|---|
|||Activities|Support|||
|||undertaken|Costs|2023|2022|
|||directly|(see note 11)|Total|Total|
|||E|E|E|E|
|Hospice inpatient|unit, day care and carer support|||||
|Wages and salaries||2,229,967|344,204|2,574,171|2,319,248|
|Depreciation|||122,019|122,019|123,804|
|Other costs||296,303|106,586|402,889|391,195|
|||2,526,270|572,809|3,099,079|2,834,247|
|Education||||||
|Wages and salaries||104,695||104,695|107,666|
|||104,695||104,695|107,666|
|||2,630,965|572,809|3,203,774|2,941,913|



## 

|remaining<br>support|costs are app|ortioned<br>bet|ween<br>the activiti|es<br>undertaken|as shown be|low.|||
|---|---|---|---|---|---|---|---|---|
|||General|Governance||||||
|||Support|Function|Total|Basis of apportionment||||
|||E|E|E|||||
|Audit and accountancy|||7,150|7,150|Governance||||
|Legal fees|||11,420|11,420|Governance||||
|Other professional|fees||2,281|2,281|Governance||||
|Other governance|expenditure||4,143|4,143|Governance||||
|Finance and administration|||||||||
|salaries,<br>wages and related<br>costs||624,759||624,759|Allocated<br>on <br>expenditure|total revenue,<br>and number<br>of||total<br> employees|
|Finance and administration<br>other expenditure||73,827||73,827|Allocated on <br>expenditure|total revenue,<br>and number<br>of||total<br> employees|
|ITcosts||66,514||66,514|Allocated on|number<br>of|employees||
|Depreciation||147,060||147,060|Allocated<br>on|total assets|||
|Other support costs||43,191||43,191|Allocated<br>on <br>expenditure|total revenue||Et total|
|||955,351|24,994|980,345|||||



## 

|Net expe|nditure<br>for the year|||||
|---|---|---|---|---|---|
|||||2023|2022|
|||||E|E|
|This is stated after charging:||||||
|Depreciation||||147,060|143,154|
|Auditor's|remuneration:|||||
|For the|provision of audit services to the group|||11,100|9,495|
|For the|provision of taxation|advisory services not included|above|200|1,950|





## 

## 

|Analysis of|staff costs|||||
|---|---|---|---|---|---|
|||||2023|2022|
|||||E|E|
|Wages and|salaries|||3,389,815|2,934,241|
|Social security costs||||304,920|261,769|
|Contribution|to defined contribution|pension|schemes|163,206|154,977|
|||||3,857,941|3,350,987|



||The number of employees|whose emoluments|whose emoluments|(excluding|employer|pension costs) fell|within the following|bands is||
|---|---|---|---|---|---|---|---|---|---|
||set out below:|||||||||
||E60,000<br>- E70,000||||||||3|
||E70,000<br>- E80,000||||||3|||
||E90,000<br>- E100,000||||||||1|
||E100,000<br>- E110,000||||||1|||
|14|Staff numbers,<br>Trustee remuneration||and expenses and||the cost|of key management|personnel|||



||||2023|2022|
|---|---|---|---|---|
|Hospice inpatient|unit, day therapy|and patient support|74|75|
|Fundraising|||10|9|
|Retail|||26|25|
|Administration|||17|16|
||||127|125|



## 

|Tangible fixed assets||||||
|---|---|---|---|---|---|
||Freehold|Leasehold|Ffxtul'es,|||
|Group and Charity|property<br>and|property<br>and|fittings and|Motor||
||improvements|improvements|equipment|vehicles|Total|
|Cost|E|E|E||E|
|At 1 April 2022|3,444,086|150,453|799,551|23,276|4,417,366|
|Disposals|||(25,696)||(25,696)|
|Additions|128,277|2,050|83,187|5,809|219,323|
|At 31 March 2023|3,572,363|152,503|857,042|29,085|4,610,993|
|Depreciation||||||
|At 1 April 2022|948,811|109,445|625,862|23,276|1,707,394|
|Disposals|||(25,696)||(25,696)|
|Charge for the year|71,125|14,480|60,694|761|147,060|
|At 31 March 2023|1,019,936|123,925|660,860|24,037|1,828,758|
|Net Book Value||||||
|At 31 March 2023|2,552,427|28,578|196, 82|5,048|2,782,235|
|At 31 March 2022|2, 95,275|41.008|73.689||2,709,972|





## 

|16|Investment<br>properties||||
|---|---|---|---|---|
||||Freehold investment|property|
||Group and Charity||2023|2022|
||||E|E|
||Valuation at beginning|ofyear|513,002|645,633|
||Disposal proceeds||(167,997)|(80,114)|
||Gains<br>/ (losses) on disposal||12,997|(1,386)|
||Reclassification<br>of bank|accounts||(78,833)|
||Surplus<br>on revaluation||65,498|27,702|
||Valuation at end of year||23,|513,002|



## 

|Investments||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||||Listed investments||
|||||||||||||||2023|2022|
|Group||||||||||||||E|E|
|Valuation at beginning<br>ofyear||||||||||||||471,121|470,483|
|Additions||||||||||||||47,453|75,136|
|Disposals||||||||||||||(51,780)|(76,781)|
|Net movement|in deposits|||||||||||||(876)|(619)|
|Net investment|gains|||||||||||||(21,843)|2,902|
|Valuation at end of||year||||||||||||444,075|1. 21|
|||||||||Investments|||In|Listed||Total||
|||||||subsidiary|||companies|||investments||2023|2022|
|Charity|||||||||E|||||E|E|
|Valuation at beginning|||of year||||||||2|471,121||471,123|470,485|
|Additions||||||||||||47,453||47,453|75,136|
|Disposals||||||||||||(51,780)||(51,780)|(75,839)|
|Net movement|in deposits|||||||||||(876)||(876)|(619)|
|Net investment|gains|||||||||||(21,843)||(21,843)|1,960|
|Valuation at end of||year|||||||||2|444,075||444,077|471,123|
|Listed investments||are those||listed on a recognised||stock|exchange|||or|are|held in units of common<br>investment<br>funds||||
|where the values are|||calculated||by reference to investments|||quoted||on a recognised|||stock exchange.|||
|At the year end|no|individual||investment<br>amounts||to more|than||6.0%of||the|portfolio|value (2022: 5.6%).|||
|3 fund<br>investments|||held at|the|year end were greater||than||5%|(2022:||3); Fundsmith||LLP sustainable|equity<br>DIS|
|(6.0%), Fidelity|UCITS ICA US Qual Inc (5.6%), SSGA|||||SPDR ETFS||E|(5.6%)|||||||
|||||||||||||||Market|Market|
|||||||||||||||Value|Value|
|||||||||||||||2023|2022|
|||||||||||||||E|E|
|UK equities||||||||||||||136,425|112,976|
|Overseas equities||||||||||||||193,873|230,048|
|UK government|bonds|||||||||||||7,87D|82,873|
|Company<br>bonds||||||||||||||99,324|37,765|
|Cash Funds||||||||||||||6,583|7,459|
|||||||||||||||444,075|471,12|
|Historical cost at end|||ofyear|||||||||||01,301|02,705|





## 

## 

|Investments<br>(continued)<br>Principal<br>subsidiaries|Investments<br>(continued)<br>Principal<br>subsidiaries||||||
|---|---|---|---|---|---|---|
|The following<br>was a subsidiary||undertaking|of the Charity:||||
|Name|||Company<br>number|Registered<br>372|Principal|activity|
|Wakefield<br>Hospice Trading|Limited||02768457|England|Trading|Subsidiary|
|Class ofshares||Holding|Included<br>in|consolidation|||
|Ordinary||100%|Yes||||



||The fina|n|cial|r|es|ults|ofth|e subsidiary<br>for the year wer|e:||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||Name||||||||Income|Expenditure|Profit for<br>the year|Net assets|
||||||||||E|E|E||
||Wakefieid||Hospice Trading|||||Limited|31,784|20,063|11,721|8,417|
|18|Stocks||||||||||||
||||||||||||2023|2022|
||Group||||||||||E.|E|
||Finished||goods||and||goods for resale||||14,186|7, 82|
|19|Debtors||||||||||||
||||||||||Group|Group|Charity|Charity|
||||||||||2023|2022|2023|2022|
|||||||||||E|E|E|
||Trade debtors||||||||307,156|193,382|307,156|193,382|
||Amounts||owed||by group undertakings||||||11,721|7,818|
||Prepayments|||and||accrued||income|810,689|757,349|810,689|757,349|
||Other debtors||||||||29,553|26,259|29,553|26,259|
||||||||||1,147,398|976,990|1,159,119|984,808|
|20|Creditors: Amounts||||||falling due within one year||||||
||||||||||Group|Group|Charity|Charity|
||||||||||2023|2022|2023|2022|
||||||||||E|E|E|E|
||Trade creditors||||||||150,395|125,848|149,942|125,848|
||Accruals||||||||313,813|128,917|309,664|125,530|
||Deferred||income|||(see note||21)|9,377|23,156|9,377|23,156|
||Other taxation||||and||social security||64,940|59,795|64,480|59,434|
||Other creditors||||||||36,288|24,196|36,288|24,196|
||||||||||574,813|361,912|569,751|358,164|
|21|Deferred||income||||||||||
||||||||||Group|Group|Chadty|Charity|
||||||||||2023|2022|2023|2022|
||||||||||E|E|E|E|
||Balance|as at||1|April 2022||||23,156|1,067,182|23,156|1,067,182|
||Amount|released||||to|income from prior periods||(23,156)|(1,067,182)|(23,156)|(1,067,182)|
||Amount|deferred||||in|year||9,377|23,156||23,156|
||Balance|as at||31 March 2023|||||9,377|23,156|6,377|23.186|





## 

## 

|Group|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||2023|2022|
|Financial|assets||||||||E|E|
|Financial|assets measured||at|fair value|through||income and expenditure|account|867,575|984,123|
|Financial|assets measured||at|amortised|cost||||2,026,666|2,289,408|
|||||||||||3,273,531|
|Financial|liabilities||||||||||
|Financial|liabilities|measured||at amortised||cost|||500,496<br>5,|278,961<br>278.961|
|Charity|||||||||||
||||||||||2023|2022|
|Financial|assets||||||||E|E|
|Financial|assets measured||at|fair value|through||income and expenditure|account|867,577|984,125|
|Financial|assets measured||at|amortised|cost||||2,027,373|2,284,725|
||||||||||9 .95|3,268,858|
|Financial|liabilities||||||||||
|Financial|liabilities|measured||at amortised||cost|||495,894|275,574|
||||||||||495,894|275,5|



## 

|Funds|||||||||
|---|---|---|---|---|---|---|---|---|
||||Balance at<br>1 April<br>2022|Income|Expenditure|Transfers|Gains and<br>losses|Balance at<br>31 March<br>2023|
||||E|||||E|
|Restricted|Funds||||||||
|Restricted|funds||114,689|23,479|(28,702)|(35,000)||74,466|
|Unrestricted<br>Funds|||||||||
|Designated|funds:||||||||
|Capital fund|||3,309,972|219,323|(147,060)|||3,382,235|
|General<br>funds|||2,961,761|4,306,894|(4,890,470)|35,000|56,652|2,469,837|
|Toto(|Unrestricted|Funds|6,271,733|4,526,217|(5,037,530)|35,000|56,652|5,852,072|
||||6,386,422|4,549,696|(5,066,232)||56,652|5,926,538|



## 



## 

## 

## 

## 

## 


## 

## 

## 



## 

## 

## 

|Group and Charit|y||||||||
|---|---|---|---|---|---|---|---|---|
|The total future|minimum|lease|payments|under non-cancellable|operating|leases|are as follows:<br>2023|2022|
|Operating<br>leases|which expire:||||||E|E|
|Within one year|||||||19,859|96,065|
|Within two to five years|||||||268,480|76,489|
|Over five years|||||||130,403<br>,742», 55||



## 

## 

## 

## 

||||2023|2022|2022|2022|
|---|---|---|---|---|---|---|
||||Total|Unrestricted|Restricted|Total|
||||Funds|Funds|Funds|Funds|
||||E|E|E|E|
|Income:|||||||
|Income from donations<br>and||legacies|1,175,459|1,186,321|106,151|1,292,472|
|Income from charitable<br>activities|||1 659 623|1,441,191||1,441,191|
|Income from other|trading|activities|1,665,017|1,457,709||1,457,709|
|Investment<br>income|||49,597|36,568||36,568|
|Other income||||31,702||31,702|
|Total Income|||4,549,696|4,153,491|106,151|4,259,642|
|Expenditure:|||||||
|Expenditure<br>on raising<br>funds|||1,862,458|1,453,293||1,453,293|
|Expenditure<br>on charitable||activities|3,203,774|2,929,345|12,568|2,941,913|
|Total expenditure|||5,066,232|4,382,638|12,568|4,395,206|
|Net gains on investments|||56,652|29,218||29,218|
|Net (expenditure)|/ income||(459,884)|(199,929)|93,583|(106,346)|
|Transfers<br>between|funds|||70,507|(70,507)||
|Net Movement<br>in Funds|||(459,884)|(129,422)|23,076|(106,346)|
|Reconciliation<br>offunds:|||||||
|Total funds brought|forward||6,386,422|6,401,155|91,613|6,492,768|
|Total funds carried|forward||5,926,538|6,271,733|114,689|6,386,422|





## 

|30|Analysis ofexp|en|diture|on|raising fu|nds com|parative<br>note|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||Activities|Support||
|||||||||2023|undertaken|Costs|2022|
|||||||||Total|directly|lsee note 32)|Total|
|||||||||E|E|E|E|
||Fundraising|||||||||||
||Wages and|salaries||||||447,968|217,925|114,216|332,141|
||Depreciation|||||||4,894||4,966|4,966|
||Other costs|||||||239,803|151,853|21,801|173,654|
|||||||||692,665|369,778|140,983|510,761|
||Retail|||||||||||
||Wages and|salaries||||||731,106|474,916|117,016|591,932|
||Expenditure|ofWakefield|||Hospice|Trading|Limited|20,063|14,410||14,410|
||Depreciation|||||||20,147||14,384|14,384|
||Other costs|||||||349,707|242,986|29,101|272,087|
|||||||||1,121,023|732,312|160,501|892,813|
||Other expenditure||on raising||funds|||||||
||Investment|management|||fees|||10,071|11,536||11,536|
||General income costs|||||||13,705|4,&36||4,836|
|||||||||23,776|16,372||16,372|
||Governance|||||||24,994||33,347|33,347|
|||||||||1,862,458|1,118,462|334,831|1,453,293|
|31|Analysis ofexpenditure|||on|charitable|activities comparative||note||||
||||||||||Activities|Support||
|||||||||2023|undertaken|Costs|2022|
|||||||||Total|directly|lsee note 32)|Total|
|||||||||E|E|E|E|
||Hospice inpatient||unit, day care and carer support|||||||||
||Wages and|salaries||||||2,574,171|2,010,879|308,369|2,319,24&|
||Depreciation|||||||122,019||123,804|123,804|
||Other costs|||||||402,889|310,594|80,601|391,195|
|||||||||3,099,079|2,321,473|512,774|2,834,247|
||Education|||||||||||
||Wages and|salaries||||||104,695|107,666||107,666|
|||||||||1O4,695|107,666||107,666|
|||||||||3,203,774|2,429,139|512,774|2,941,913|



## 




## 

## 

|Funds com|parative<br>no|te|||||||
|---|---|---|---|---|---|---|---|---|
||||Balance at<br>1 April<br>2021|Income|Expenditure|Transfers|Gains and<br>losses|Balance at<br>31 March<br>2022|
||||E|||||E|
|Restricted|Funds||||||||
|Restricted|funds||91,613|106,151|(12,568)|(70,507)||114,689|
|Unrestricted<br>Funds|||||||||
|Designated|funds:||||||||
|Capital<br>fund|||2,799,273|53,853|(143,154)|600,000||3 309 972|
|General<br>funds|||3,601,882|4,099,638|(4,239,484)|(529,493)|29,218|2,961,761|
|Total|Unrestricted|Funds|6,401,155|4,153,491|(4,382,638)|70,507|29,218|6,271,733|
||||6, 92,768|4,259,6 2|1,395,2063|-|29,2 8|6,386,422|



|Analysis o|f n|et assets be|tween<br>funds compa|rative<br>note||||
|---|---|---|---|---|---|---|---|
||||Fixed Assets|Investment<br>Properties|Investments|Net Current<br>Assets|Tot<br>I|
||||||E|E|E|
|Restricted|funds|||||114,689|114,689|
|Unrestricted||funds:||||||
|Designated||funds|2,709,972|||600,000|3,309,972|
|General|funds|||513,002|471,121|1,977,638|2,961,761|
||||2,709,972|513,00|471,121|2,692,327|6,386,422|